Company: BCHT
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001477932-25-003808
Chunk: 115

Company: Birchtech Corp.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 8
Chunk 115
---
 valuation assumptions included an expected duration of 5 years, volatility of 92%, discount rate of 4.46% and dividends of $0. A summary of stock option activity is presented below:        Weighted       Weighted    Average      Number  Average    Remaining  Aggregate   of  Exercise  Contractual  Intrinsic   Shares   Price   Life (years)  Value December 31, 2024  9,300,000  $0.58   1.75   12,500                  Grants  350,000   0.52         March 31, 2025  9,650,000  $0.58   1.57   901,750                  Options exercisable at:                March 31, 2025  9,400,000   0.58   1.54   901,750  The aggregate intrinsic value in the table above represents the total intrinsic value, based on the Company’s closing stock price of $0.50 as of March 31, 2025, which would have been received by the option holders had all option holders exercised their options as of that date. There were no stock options exercised during the three months ended March 31, 2025. Stock options exercised during the three months ended March 31, 2024 include none that were exercised for cash and 18,750 which were a cashless exercise. Restricted Share Units On January 15, 2024, the Company granted 50,000 restricted share units (“RSUs”) to a director pursuant to the 2017 Plan. The RSUs will vest one year from the date of grant on January 15, 2025. Once vested, each RSU represents the right to receive one share of the Company’s common stock. These shares of common stock were valued at $43,500 in accordance with FASB ASC Topic 718. The fair value of the shares will be amortized as an expense over the vesting period. The shares become fully vested on January 15, 2025. The expense for the three months ended March 31, 2025 and 2024 was $1,668 and $9,058, respectively. On January 15, 2025, the